Where science becomes programmable medicine
Revolutionizing drug delivery through 3D printing technology.
We develop, validate, and transfer new forms of personalized medication through our MESO-PP® technology, integrating research, clinical practice, and production within a single system.
Science validated in every prescription
Unlike traditional models, at PILL.AR Academy research doesn’t end in the laboratory.
Each formulation can be applied, measured, and optimized in real-world settings through the PIA prescription platform, generating continuous clinical evidence.
A system where each treatment helps improve the next one.
From evidence to production
At PILL.AR Academy, knowledge is translated into therapeutic protocols ready for implementation.
Each development integrates formulation, production parameters, in-process controls, and clinical context, enabling its application in real-world settings with full traceability.
This turns research into a validated production capability.
What is Pill.ar Academy
The research, training, and validation unit of PILL.AR, created in collaboration with the National University of Córdoba and CONICET.
Here, science, clinical practice, and technology converge to design, validate, and scale new pharmaceutical forms based on additive manufacturing.
Impact
International MESO-PP® patent
First validation of pharmaceutical 3D printing in a real-world setting
Direct integration with medical prescription (PIA)
Continuous generation of clinical evidence
Development of therapeutic protocols applicable in production
What are we researching?
Personalized multi-drug systems
Controlled-release technologies
Nanotechnology applied to formulations
Evidence-based therapeutic personalization
An innovation ecosystem
PILL.AR Academy integrates:
Academic institutions
Research centers
Clinics
Pharmacies
To bring innovation from the laboratory to the patient, closing the loop between research, validation, and production.
Clinical-scientific space
We promote interdisciplinary spaces where:
Real cases are analyzed
Personalized therapeutic criteria are defined.
Formulations are optimized based on evidence.
These environments directly link clinical practice with knowledge generation.
Why collaborate with Pill.ar Academy?
Access to a real platform for clinical and technological validation.
Development of formulations with direct impact on patients.
Integration of research with pharmaceutical production.
Participation in technology transfer processes.
Access to academic, clinical, and regulatory networks.
Who can be part of it?
Students → theses and applied projects
Researchers and institutions → validation and scaling of developments
Healthcare professionals → co-design and validation of personalized therapeutic strategies
Companies and startups → development and reformulation of products in PILL.AR format
Healthcare centers → implementation of personalized treatments
Organizations → development of impactful healthcare solutions
Let’s build the future of pharmacotherapy in medication
If you want to be part of a new way of designing, validating, and producing personalized treatments, this is the place.
For academic and scientific inquiries, you can contact directly:
Dr. Santiago Palma, CSO, PILL.AR
sdpalma@unc.edu.ar
